IOLCP.NS Earnings Date: Oct 30, 2026 (Estimated) — IOL Chemicals and Pharmaceuticals Limited

NSE

Updated Oct 30, 2026

Price —

Market Cap $54.3B

P/E 31.4

52W Range — – —

Next Earnings Oct 30, 2026 (est.)

When is IOLCP.NS's next earnings date?

IOL Chemicals and Pharmaceuticals Limited (IOLCP.NS) is expected to report earnings on Friday, October 30, 2026; the date is an estimate and has not been confirmed by the company. The consensus estimate is revenue of $7.60B.

How did IOLCP.NS do in its last earnings report?

In its most recent report on Aug 10, 2026, IOL Chemicals and Pharmaceuticals Limited posted EPS of $2.22. Revenue was $7.63B against a $6.47B estimate.

About IOL Chemicals and Pharmaceuticals Limited

Established in 1986 and headquartered in Ludhiana, India, IOL Chemicals and Pharmaceuticals Limited operates as a global manufacturer and supplier of diverse pharmaceutical and chemical products. Its pharmaceutical portfolio encompasses a wide array of active pharmaceutical ingredients (APIs), featuring prominent pain and fever relievers such as ibuprofen, ibuprofen lysinate, ibuprofen sodium, and dex-ibuprofen. The company also provides other crucial APIs, including metformin hydrochloride, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, lamotrigine, and fenofibrate. These compounds are integral to treatments addressing various conditions, such as inflammation, pain relief, fever reduction, diabetes, platelet aggregation, cholesterol management, seizures, gallstones, and gastric acid inhibition. In addition to pharmaceuticals, IOL supplies specialized industrial chemicals like ethyl acetate, iso butyl benzene, acetyl chloride, and mono chloro acetic acid. These chemicals are widely utilized across numerous industries, including food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and as chemical intermediates.